Psycho-Babble Medication Thread 8852

Shown: posts 1 to 1 of 1. This is the beginning of the thread.

 

Clinical trials

Posted by saintjames on July 17, 1999, at 22:42:10

If you happen to be in MA contact centerwatch if you want to be a paid study
subject.

james

This email is being sent to notify you that the following new trial(s) in
your area of interest have been posted on the CenterWatch web site at
http://www.centerwatch.com.

1) A Double-Blind, Parallel, Comparison of Hypericum, Fluoxetine, and
Placebo in Major Depressive Disorder. This study is being conducted in:
- Boston, MA
2) A Double-blind, Placebo Controlled Study of ST. JOHN'S WORT in Depressed
Outpatients. This study is being conducted in:
- Belmont, MA
3) A Double-blind, Placebo Controlled, Parallel Assessment of the Safety and
Efficacy of the Selegiline Transdermal System in Patients with Major
Depression. This study is being conducted in:
- Belmont, MA
4) Folate Metabolism in the Management of Treatment Refractory Depression.
This study is being conducted in:
- Boston, MA
5) Olanzapine Alone and in Combination with Antidepressants versus Placebo
in Major Depressive Disorder with Psychotic Features. This study is being
conducted in:
- Boston, MA
6) Pre-menstrual worsening of depression. This study is being conducted in:
- Boston, MA
7) Prediction of Outcome During Fluoxetine Continuation. This study is being
conducted in:
- Boston, MA
8) Reboxetine (PNU-1559OE) versus Placebo and Fluoxetine in a controlled,
randomized, double-blind, multi-center study of treatment in Major
Depressive Disorders. This study is being conducted in:
- Boston, MA
9) The Combination of Olanzapine and Antidepressants in Psychotic Major
Depression: Relapse Rates Following Antidepressant Discontinuation. This
study is being conducted in:
- Boston, MA

---------------------------------------------------------

Important Update:

For news and reports on recent advances in clinical research, we invite you
to visit the CenterWatch Research Headlines Page, at
http://www.centerwatch.com/headlines.

This new area on our site has been developed by CenterWatch, in
collaboration with PDR.net and American Health Consultants.

http://www.centerwatch.com/headlines

---------------------------------------------------------
You may unsubscribe from this notification service at any time by using the
form at http://www.centerwatch.com/patemail.htm, entering your email address
and clicking on the UNSUBSCRIBE button at the bottom of the form.

Thank you,

CenterWatch



This is the end of the thread.


Show another thread

URL of post in thread:


Psycho-Babble Medication | Extras | FAQ


[dr. bob] Dr. Bob is Robert Hsiung, MD, bob@dr-bob.org

Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.